We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$1.45B
AUM Growth
-$333M
Cap. Flow
-$189M
Cap. Flow %
-13.09%
Top 10 Hldgs %
62.93%
Holding
58
New
1
Increased
5
Reduced
10
Closed
5

Top Buys

Rank Stock Value
1
GERN icon
Geron
GERN
+$14.3M
2
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$7.52M
3
ADXN
Addex Therapeutics
ADXN
+$5.77M
4
SNTI icon
Senti Biosciences Holdings
SNTI
+$427K
5
UP icon
Wheels Up
UP
+$52.3K

Top Sells

Rank Stock Value
1
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$66.2M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$50.2M
3
COUR icon
Coursera
COUR
+$38.8M
4
NET icon
Cloudflare
NET
+$34.2M
5
CBIO
Crescent Biopharma
CBIO
+$9.46M

Sector Composition

Rank Sector Weight
1 Healthcare 67.32%
2 Technology 13.44%
3 Consumer Staples 10.25%
4 Industrials 7.8%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELC icon
26
Celcuity
CELC
$4.05B
$12.8M 0.89%
1,250,001
– –
NKTX icon
27
Nkarta
NKTX
$206M
$12.7M 0.88%
3,568,781
– –
XFOR icon
28
X4 Pharmaceuticals
XFOR
$359M
$10.2M 0.71%
391,226
– –
TUYA
29
Tuya Inc
TUYA
$1.09B
$9.33M 0.64%
4,934,640
– –
CSBR icon
30
Champions Oncology
CSBR
$66.4M
$6.89M 0.48%
1,713,720
– –
UTRS
31
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$6.8M 0.47%
1,721,853
+1,221,897
+244% +$7.52M
BDTX icon
32
Black Diamond Therapeutics
BDTX
$113M
$6.52M 0.45%
3,448,757
– –
CBIO
33
Crescent Biopharma
CBIO
$698M
$6M 0.42%
47,644
-42,033
-47% -$9.46M
LXRX icon
34
Lexicon Pharmaceuticals
LXRX
$894M
$5.79M 0.4%
2,382,286
– –
IVA
35
Inventiva
IVA
$912M
$4.99M 0.35%
1,462,586
– –
SNTI icon
36
Senti Biosciences Holdings
SNTI
$9.34M
$4.92M 0.34%
470,039
+27,424
+6% +$427K
ACRV icon
37
Acrivon Therapeutics
ACRV
$78.4M
$4.89M 0.34%
481,677
– –
GOSS icon
38
Gossamer Bio
GOSS
$63.4M
$4.37M 0.3%
43,343
– –
AFMD
39
DELISTED
Affimed
AFMD
$3.3M 0.23%
442,649
– –
SYBX
40
DELISTED
Synlogic
SYBX
$2.67M 0.18%
281,929
– –
STSA
41
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$1.6M 0.11%
2,294,095
-698,863
-23% -$643K
RGLS
42
DELISTED
Regulus Therapeutics
RGLS
$1.22M 0.08%
1,445,114
– –
ADXN
43
Addex Therapeutics
ADXN
$4.13M
$1.11M 0.08%
282,435
+228,435
+423% +$5.77M
EAR
44
DELISTED
Eargo, Inc. Common Stock
EAR
$1.06M 0.07%
226,000
-10
-0% -$83
MIMO
45
DELISTED
Airspan Networks Holdings Inc
MIMO
$941K 0.07%
1,359,842
-22,458
-2% -$27.7K
MRKR icon
46
Marker Therapeutics
MRKR
$19.5M
$761K 0.05%
1,071,428
-1
-0% -$2
UP icon
47
Wheels Up
UP
$119M
$682K 0.05%
5,542
+236
+4% +$52.3K
NOTE
48
DELISTED
FiscalNote
NOTE
$576K 0.04%
25,612
-115,582
-82% -$4.7M
OBSV
49
DELISTED
ObsEva SA Ordinary Shares
OBSV
$500K 0.03%
4,586,563
– –
AKTX
50
Akari Therapeutics
AKTX
$20M
$82.2K 0.01%
565
– –
1
2
3

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q1 2023 Portfolio in Review

As of Q1 2023, NEA Management Company held 58 positions worth $1.45B, down 19% from $1.78B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

NEA Management Company withdrew a net $189M in Q1 2023, closing 5 positions and reducing 10 holdings. Its most notable exit was Oyster Point Pharma, Inc. Common Stock, an estimated $66.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 71% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, NEA Management Company opened a new position in Palo Alto Networks worth $15.6K.

  • NEA Management Company's largest Q1 2023 buy was Palo Alto Networks: 156 shares worth $15.6K.
  • NEA Management Company added most to Geron in Q1 2023, an estimated $14.3M increase.
  • NEA Management Company's biggest Q1 2023 reduction was Rhythm Pharmaceuticals, cutting an estimated $50.2M.
  • NEA Management Company fully exited Oyster Point Pharma, Inc. Common Stock in Q1 2023, selling an estimated $66.2M.
  • NEA Management Company's ten largest holdings make up 63% of its $1.45B portfolio in Q1 2023.
  • NEA Management Company opened 1 new position and closed 5 in Q1 2023.
  • NEA Management Company's portfolio value fell 19% quarter-over-quarter to $1.45B.

Based on NEA Management Company's 13F filing for Q1 2023, filed 15 May 2023.